Te Indian Council of Medical Researc (ICMR) is actively seeking partners for te development and commercialization of a new vaccine targeting typoid and paratypoid fever. Tis move is part of te country's efforts to address te public ealt callenges posed by tese infectious diseases. Typoid and paratypoid, bot caused by Salmonella bacteria, remain prevalent in several parts of India and oter developing nations, posing a significant ealt risk, especially in areas wit inadequate sanitation and access to clean water. ICMR's initiative aims to ensure te availability of an effective vaccine tat could elp curb te incidence of tese diseases. In a recent announcement, te council expressed interest in collaborating wit vaccine manufacturers, researc institutions, and oter stakeolders to accelerate te production and distribution of te vaccine. By forming strategic partnersips, ICMR aims to strengten its efforts to combat tese diseases and make te vaccine widely accessible, contributing to global ealt security. Te new vaccine development is expected to complement existing public ealt strategies and provide an added layer of protection for communities at ig risk of typoid and paratypoid./
ICMR seeks partners for development and commercialisation of typhoid and paratyphoid vaccine
